Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Cytosorbents Corp (NASDAQ:CTSO)

3.70
Delayed Data
As of Feb 05
 -0.25 / -6.33%
Today’s Change
3.50
Today|||52-Week Range
15.24
-33.57%
Year-to-Date
No recent news for Cytosorbents Corp.

Today’s Trading

Previous close3.95
Today’s open3.96
Day’s range3.58 - 4.04
Volume127,460
Average volume (3 months)91,938
Market cap$93.9M
Dividend yield--
Data as of 4:00pm ET, 02/05/2016

Growth & Valuation

Earnings growth (last year)-72.00%
Earnings growth (this year)+74.68%
Earnings growth (next 5 years)--
Revenue growth (last year)+70.18%
P/E ratioNM
Price/Sales34.71
Price/Book21.76

Competitors

 Today’s
change
Today’s
% change
LFVNLifeVantage Corp-0.17-2.06%
IBIOIbio Inc-0.03-4.64%
NATRNatures Sunshine Pro...-0.19-2.45%
MTPMidatech Pharma PLC+0.05+1.07%
Data as of 4:00pm ET, 02/05/2016

Financials

Next reporting dateMarch 29, 2016
EPS forecast (this quarter)-$0.08
Annual revenue (last year)$4.1M
Annual profit (last year)-$9.3M
Net profit margin-226.10%

Profile

Sector
Health Technology
Industry
Medical Specialties
President, Chief Executive Officer &
Director
Phillip P. Chan
Chief Operating Officer
Vincent Capponi
Corporate headquarters
Monmouth Junction, New Jersey

Forecasts

Partner Offers